HighTower Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Sell |
9,747
-17,033
| -64% | -$367K | ﹤0.01% | 3217 |
|
|
2025
Q1 | $445K | Buy |
+26,780
| New | +$445K | ﹤0.01% | 2549 |
|
|
2022
Q2 | – | Sell |
-44,485
| Closed | -$1.08M | – | 2979 |
|
|
2022
Q1 | $1.08M | Buy |
+44,485
| New | +$1.08M | ﹤0.01% | 1709 |
|
|
2021
Q1 | – | Sell |
-4,959
| Closed | -$265K | – | 2832 |
|
|
2020
Q4 | $265K | Buy |
+4,959
| New | +$265K | ﹤0.01% | 1984 |
|
|
2019
Q2 | – | Sell |
-29,043
| Closed | -$776K | – | 2251 |
|
|
2019
Q1 | $776K | Buy |
+29,043
| New | +$776K | 0.01% | 1246 |
|
|
2018
Q4 | – | Sell |
-9,687
| Closed | -$200K | – | 2075 |
|
|
2018
Q3 | $200K | Buy |
+9,687
| New | +$200K | ﹤0.01% | 1956 |
|
|
2018
Q2 | – | Sell |
-15,695
| Closed | -$349K | – | 2103 |
|
|
2018
Q1 | $349K | Buy |
15,695
+580
| +4% | +$12.9K | ﹤0.01% | 1600 |
|
|
2017
Q4 | $456K | Buy |
15,115
+3,057
| +25% | +$92.2K | ﹤0.01% | 1488 |
|
|
2017
Q3 | $456K | Buy |
12,058
+237
| +2% | +$8.96K | ﹤0.01% | 1481 |
|
|
2017
Q2 | $330K | Buy |
11,821
+1,450
| +14% | +$40.5K | ﹤0.01% | 1565 |
|
|
2017
Q1 | $356K | Buy |
10,371
+1,175
| +13% | +$40.3K | ﹤0.01% | 1467 |
|
|
2016
Q4 | $265K | Buy |
9,196
+1,499
| +19% | +$43.2K | ﹤0.01% | 1535 |
|
|
2016
Q3 | $245K | Buy |
7,697
+1,200
| +18% | +$38.2K | ﹤0.01% | 1548 |
|
|
2016
Q2 | $208K | Buy |
6,497
+1,337
| +26% | +$42.8K | ﹤0.01% | 1475 |
|
|
2016
Q1 | $144K | Buy |
+5,160
| New | +$144K | ﹤0.01% | 1791 |
|
|
2015
Q2 | – | Sell |
-6,236
| Closed | -$203K | – | 1516 |
|
|
2015
Q1 | $203K | Buy |
+6,236
| New | +$203K | ﹤0.01% | 1429 |
|